Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1249401.RAX4J1yweIPwK9zggyeP0THvdUVH62rdhzJyikPfxnF6s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1249401.RAX4J1yweIPwK9zggyeP0THvdUVH62rdhzJyikPfxnF6s130_assertion type Assertion NP1249401.RAX4J1yweIPwK9zggyeP0THvdUVH62rdhzJyikPfxnF6s130_head.
- NP1249401.RAX4J1yweIPwK9zggyeP0THvdUVH62rdhzJyikPfxnF6s130_assertion description "[Therefore, inhibiting the activation of AhR may represent a potentially attractive therapeutic target for ccRCC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249401.RAX4J1yweIPwK9zggyeP0THvdUVH62rdhzJyikPfxnF6s130_provenance.
- NP1249401.RAX4J1yweIPwK9zggyeP0THvdUVH62rdhzJyikPfxnF6s130_assertion evidence source_evidence_literature NP1249401.RAX4J1yweIPwK9zggyeP0THvdUVH62rdhzJyikPfxnF6s130_provenance.
- NP1249401.RAX4J1yweIPwK9zggyeP0THvdUVH62rdhzJyikPfxnF6s130_assertion SIO_000772 25523818 NP1249401.RAX4J1yweIPwK9zggyeP0THvdUVH62rdhzJyikPfxnF6s130_provenance.
- NP1249401.RAX4J1yweIPwK9zggyeP0THvdUVH62rdhzJyikPfxnF6s130_assertion wasDerivedFrom befree-2016 NP1249401.RAX4J1yweIPwK9zggyeP0THvdUVH62rdhzJyikPfxnF6s130_provenance.
- NP1249401.RAX4J1yweIPwK9zggyeP0THvdUVH62rdhzJyikPfxnF6s130_assertion wasGeneratedBy ECO_0000203 NP1249401.RAX4J1yweIPwK9zggyeP0THvdUVH62rdhzJyikPfxnF6s130_provenance.